Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 14/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8475741 | 0.89 | ADORA2A (0.46) | SCN9AKMT2AADORA2AADORA1ALOX5 | |
| SCHEMBL7252609 | 0.83 | KMT2A (0.46) | SCN9AKMT2AADORA2AADORA1 | |
| SCHEMBL5221402 | 0.79 | KMT2A (0.47) | SCN9AKMT2AADORA2AADORA1 | |
| SCHEMBL7253229 | 0.78 | GRM5 (0.42) | SCN9AKMT2AALOX5PTGS1PTGS2 | |
| SCHEMBL7250243 | 0.78 | ADORA2A (0.46) | SCN9AKMT2AADORA2AADORA1ALOX5 | |
| SCHEMBL7077095 | 0.77 | KMT2A (0.46) | SCN9AKMT2AADORA2AADORA1 | |
| SCHEMBL8932322 | 0.77 | KMT2A (0.44) | SCN9AKMT2AADORA2AADORA1ALOX5 | |
| SCHEMBL6609513 | 0.76 | KMT2A (0.38) | SCN9AKMT2AADORA2AADORA1 | |
| SCHEMBL6610715 | 0.76 | ADORA2A (0.39) | SCN9AKMT2AADORA2AADORA1 | |
| SCHEMBL8479783 | 0.76 | MMP13 (0.39) | SCN9AKMT2AADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6528456-B2 | Selectivity, desirable rate of degradation in soil | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-04 | — | — | US | disclosed |
| US-20020137633-A1 | Herbicidal 2-pyrazolyl-6-aryloxypyri(mi)dines | BASF AKTIENEGESELLSCHAFT (DE) | 2002-09-26 | — | — | US | disclosed |
| EP-1108720-A9 | Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-31 | — | — | EP | disclosed |
| EP-1108720-A1 | Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137633-A1 | Herbicidal 2-pyrazolyl-6-aryloxypyri(mi)dines | DDT, CYP4X1, PRDX6 | SCN9A 2063/4885KMT2A 966/4885ADORA2A 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.